Biocryst Pharmaceuticals Stock
Biocryst Pharmaceuticals Stock
The price for the Biocryst Pharmaceuticals stock decreased slightly today. Compared to yesterday there is a change of -€0.024 (-0.320%).
With 19 Buy predictions and not the single Sell prediction the community is currently very high on Biocryst Pharmaceuticals.
As a result the target price of 14 € shows a very positive potential of 89.55% compared to the current price of 7.39 € for Biocryst Pharmaceuticals.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Biocryst Pharmaceuticals stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Biocryst Pharmaceuticals in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biocryst Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals | -0.320% | 17.321% | 33.562% | -10.787% | 13.026% | -10.453% | -25.468% |
| Heron Therapeutics Inc. | 0.490% | -0.394% | -9.571% | -57.449% | -9.246% | -53.624% | -93.267% |
| Evolus Inc | -2.210% | -2.162% | -8.586% | -72.366% | -33.578% | -56.905% | -64.786% |
| Sangamo Therapeutics Inc. | -5.070% | 14.215% | -18.135% | -62.306% | 5.432% | -86.736% | -96.300% |
Comments
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at Evercore Inc. They set an "outperform" rating and a $17.00 price target on the stock.
Show more
Ratings data for BCRX provided by MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target lowered by analysts at Royal Bank Of Canada from $14.00 to $13.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for BCRX provided by MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target raised by analysts at HC Wainwright from $30.00 to $32.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BCRX provided by MarketBeat